Paracetamol Injection Market contains market size and forecasts of Paracetamol Injection in global, including the following market information:
- Global Paracetamol Injection Market Revenue, 2018-2023, 2023-2030, ($ millions)
- Global Paracetamol Injection Market Sales, 2018-2023, 2023-2030, (K Units)
Global top five Paracetamol Injection companies in 2022 (%)
The global Paracetamol Injection market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
10 mg/ml Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Paracetamol Injection include AdvaCare Pharma, DMS Chemical, Johnson & Johnson, Shijiazhuang No. 4 Pharmaceutical Co., Ltd., Sriya Life Science, Anhui Medipharm Co., Ltd., Reyoung Pharmaceutical Co., Ltd., Hebei Lishang Hechuang Sign Co., Ltd and Guangzhou Mandison Biotechnology Co., Ltd., etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Paracetamol Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Paracetamol Injection Market, by Specification, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Paracetamol Injection Market Segment Percentages, by Specification, 2022 (%)
- 10 mg/ml
- 120 mg/ml
- 150 mg/ml
- Others
Global Paracetamol Injection Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Paracetamol Injection Market Segment Percentages, by Application, 2022 (%)
Global Paracetamol Injection Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Paracetamol Injection Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Paracetamol Injection revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Paracetamol Injection revenues share in global market, 2022 (%)
- Key companies Paracetamol Injection sales in global market, 2018-2023 (Estimated), (K Units)
- Key companies Paracetamol Injection sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- AdvaCare Pharma
- DMS Chemical
- Johnson & Johnson
- Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
- Sriya Life Science
- Anhui Medipharm Co., Ltd.
- Reyoung Pharmaceutical Co., Ltd.
- Hebei Lishang Hechuang Sign Co., Ltd
- Guangzhou Mandison Biotechnology Co., Ltd.
- Xian Medihealth Company Ltd
- Naman Pharma Drugs
- Nanjing Sino Pharmaceutical Ltd.
- WAMIN
- Wellona Pharma
- Hebei Tianyuan Pharmaceutical Co., Ltd.
- B. Braun
Industry Market Size
